Sophia Genetics
SOPH

Sophia Genetics (SOPH) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
BTIGMaintainedBuy$9.00 from $8.00Aug 5, 2026
HC Wainwright & Co.MaintainedBuy$14.00 from $12.00Aug 5, 2026
HC Wainwright & Co.Initiated CoverageBuy$12.00Jul 20, 2026
BTIGMaintainedBuy$8.00Jun 15, 2026
BTIGMaintainedBuy$8.00May 6, 2026
BTIGMaintainedBuy$8.00 from $7.00Apr 15, 2026
GuggenheimMaintainedBuy$7.00 from $6.00Jan 26, 2026
BTIGMaintainedBuy$7.00 from $6.00Nov 10, 2025
Craig-HallumInitiated CoverageBuy$11.00Dec 18, 2024
RBC CapitalMaintainedOutperform$7.00 from $8.00Aug 7, 2024
GuggenheimInitiated CoverageBuy$6.00Jun 27, 2024
RBC CapitalMaintainedOutperform$8.00Mar 6, 2024
BTIGMaintainedBuy$8.00 from $7.00Mar 6, 2024
RBC CapitalMaintainedOutperform$8.00Jan 12, 2024
RBC CapitalInitiated CoverageOutperform$8.00Nov 29, 2023
Credit SuisseMaintainedNeutral$5.00 from $2.25May 10, 2023
Morgan StanleyMaintainedOverweight$10.00 from $11.00May 10, 2023
Morgan StanleyMaintainedOverweight$11.00 from $12.00Mar 8, 2023

Frequently asked questions

  • What is the latest analyst rating on SOPH?

    On Aug 5, 2026, BTIG maintained Sophia Genetics at Buy with a price target of $9.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.